Renal Cancer

June 28, 2018

PD-1 Targeted Immune Therapy Shows Promising Activity

Charles H. Weaver, MD
June 28, 2018

Successful Treatment of Kidney Caner with Allogeneic Blood Stem Cell Transplant

Charles H. Weaver, MD
June 28, 2018

Randomized Comparison of Interleukin-2,Alfa Interferon or Both for the Treatment

Charles H. Weaver, MD
June 21, 2018

A 4 Drug Combination of Retinoic Acid, Interferon, Interleukin-2 & Chemotherapy

Charles H. Weaver, MD
June 21, 2018

Thalidomide May Increase Effectiveness of Proleukin® in Advanced Kidney Cancer

Charles H. Weaver, MD
June 21, 2018

Immune Cells May Improve Survival in Advanced Kidney Cancer

Charles H. Weaver, MD
June 15, 2018

Nephrectomy Prior to Interferon Improves Survival for Metastatic Renal Cancer

Charles H. Weaver, MD
June 14, 2018

Outpatient Interleukin-2-Based Combination Therapy is as Effective as High-Dose

Charles H. Weaver, MD
June 14, 2018

Long-Term, Low-Dose Interleukin and Interferon for Advanced Renal Cancer

Charles H. Weaver, MD
June 13, 2018

Inhaled Interleukin-2 is Effective Palliation for Patients with Metastatic RCC

Charles H. Weaver, MD
June 8, 2018

Obesity and Hypertension May Increase the Risk of Kidney Cancer

Charles H. Weaver, MD
June 8, 2018

Radical Nephrectomy Increases Risk of Chronic Kidney Disease

Charles H. Weaver, MD